EBET's Sports Betting Brand BetTarget Secures Ring Sponsorship of Saturday's Bare Knuckle Fighting Championship to be Held at Wembley Stadium August 19, 2022 8:45 am|Fight Card Will be Distributed in Over 60 Countries and Broadcast to an Expected 133 Million Homes
GoTopless Day 2022: Support equal gender topless equality to change the world August 19, 2022 8:45 am|LAS VEGAS, Aug. 19, 2022 /PRNewswire/ — International organization, GoTopless, proudly celebrates its 15th annual GoTopless day on…
TAYLOR DEVICES ANNOUNCES FOURTH QUARTER AND FULL YEAR RESULTS August 19, 2022 8:45 am|NORTH TONAWANDA, N.Y., Aug. 19, 2022 /PRNewswire/ — Taylor Devices, Inc. (NASDAQ SmallCap: “TAYD”) announced today that it…
Moleculin Announces Completion of Third Single Ascending Dose (SAD) Cohort in Phase 1a Clinical Trial of WP1122 in the UK August 19, 2022 8:40 am|– Preliminary results of third cohort in the first-in-human Phase 1a allows Company to proceed to next single…
Couple billed hundreds of dollars for traffic tickets after car is stolen August 19, 2022 8:37 am|ALEXANDRIA, Va. (WJLA) – A couple’s car was recently stolen. If that wasn’t bad enough, it was used…
NexPoint Capital, Inc. Announces Tender Offer for Common Stock August 19, 2022 8:30 am|DALLAS, Aug. 19, 2022 /PRNewswire/ — NexPoint Capital, Inc. (the “Company”), a non-traded publicly registered business development company sponsored…
Palo Alto Networks to Present at Upcoming Investor Event August 19, 2022 8:30 am|SANTA CLARA, Calif., Aug. 19, 2022 /PRNewswire/ — Palo Alto Networks (NASDAQ: PANW), the global cybersecurity leader, announced…
CBAK Energy Enters into Strategic Partnership Agreement with Welson Power for Indian Market August 19, 2022 8:30 am|DALIAN, China, Aug. 19, 2022 /PRNewswire/ — CBAK Energy Technology, Inc. (NASDAQ: CBAT) (“CBAK Energy,” or the “Company”),…
Thinking about buying stock in Axsome Therapeutics, Foot Locker, Mind Medicine, Digital Media Solutions, or Provention Bio? August 19, 2022 8:30 am|NEW YORK, Aug. 19, 2022 /PRNewswire/ — InvestorsObserver issues critical PriceWatch Alerts for AXSM, FL, MNMD, DMS, and PRVB.
Verismo Therapeutics Announces Submission of IND Application to the FDA for SynKIR-110TM, a KIR-CAR T-cell Immunotherapy Candidate August 19, 2022 8:23 am|Company advances towards in-human clinical trials for SynKIRTM platform targeting Mesothelin-Expressing Advanced Ovarian Cancer, Cholangiocarcinoma, and Mesothelioma